Carlisle Companies news

Latest news

• CSL vereinbart Alentis-Partnerschaft: CSL-Aktie legt 1,26 Prozent zu (opens in a new tab)

  AD HOC NEWS · Oct 7, 2026

• CSL MVPs Ryan Erisman, Caroline Bricker Named ACC Swimmers of the Week (opens in a new tab)

  Swimming World Magazine · Oct 7, 2026

• AC CSL Prato Social Club (opens in a new tab)

  Transfermarkt · Oct 7, 2026

• After Winning CSL Match MVPs, Ryan Erisman & Caroline Bricker Named ACC Swimmers of the Week (opens in a new tab)

  SwimSwam · Oct 7, 2026

• CSL fixe le prix d’une émission obligataire de 1,5 milliard de dollars (opens in a new tab)

  Zonebourse Suisse · Oct 6, 2026

• CSL colloca obbligazioni societarie per 1,5 Mrd USD (opens in a new tab)

  MarketScreener Italia · Oct 6, 2026

• CSL fija el precio de una emisión de bonos corporativos por 1.500 millones USD (opens in a new tab)

  MarketScreener España · Oct 6, 2026

• Con limpieza integral reactivan actividades en la Unidad Deportiva Leonardo Gastélum, en CSL (opens in a new tab)

  Palabra BCS · Oct 6, 2026

• CSL, Alentis Partner on Claudin-1 MAb Lixudebart for Kidney Disease (opens in a new tab)

  BioPharm International · Oct 6, 2026

• Lazio - Calcio a 5 Dilettanti Serie D Roma B G1 - CSL Soccer 21 8.0 vs Fregene 1948 (opens in a new tab)

  Tuttocampo · Oct 6, 2026

• Only One BMW M4 CSL Exists in Frozen Tampa Bay Green (opens in a new tab)

  Autoblog · Oct 6, 2026

• CSL and Alentis ink $1.5bn partnership to progress antifibrotic drug (opens in a new tab)

  Pharmaceutical Technology · Oct 6, 2026

• CSL (ASX:CSL) Could Be 15% Undervalued After Its $355 Million Alentis Deal (opens in a new tab)

  Yahoo Finance · Oct 6, 2026

• Sofrimento no trabalho. CSL oferece consultas gratuitas de apoio psicológico aos trabalhadores no Luxemburgo (opens in a new tab)

  contacto.lu · Oct 6, 2026

• CSL Aktie: Entwickelt Lixudebart exklusiv mit Alentis (opens in a new tab)

  Finanztrends · Oct 6, 2026

• Secondo Jefferies, l'accordo di licensing di CSL con Alentis potrebbe portare a un mercato indirizzabile complessivo di quasi 2 Mrd USD l'anno (opens in a new tab)

  MarketScreener Italia · Oct 6, 2026

• L’accord de licence de CSL avec Alentis devrait déboucher sur un marché adressable total pouvant atteindre près de 2 milliards de dollars par an, selon Jefferies (opens in a new tab)

  Zonebourse Suisse · Oct 6, 2026

• Roundup: CSL & Alentis Enter Global Partnership, Jiangsu Nhwa Enters Global Licensing Deal with Somnivera (opens in a new tab)

  Pharmaceutical Executive · Oct 6, 2026

• CSL Chenôve - Rekord-Abgänge (Galerie) (opens in a new tab)

  Transfermarkt · Oct 6, 2026

• Jornadas de fumigación contra el dengue en CSL (opens in a new tab)

  Palabra BCS · Oct 5, 2026

• CSL strikes up to $1.6B deal with Alentis for autoimmune drug with broad potential (opens in a new tab)

  BioSpace · Oct 5, 2026

• CSL, Alentis partner on claudin-1 antibody in $1.5B deal (opens in a new tab)

  FirstWord Pharma · Oct 5, 2026

• Schweizer Alentis holt CSL an Bord (opens in a new tab)

  transkript.de · Oct 5, 2026

• CSL & Alentis Enter $1.6 Billion Global Partnership | PharmExec (opens in a new tab)

  Pharmaceutical Executive · Oct 5, 2026

• CSL and Alentis strike $1.6bn collab for rare kidney and liver diseases (opens in a new tab)

  BioXconomy · Oct 5, 2026

• CSL y Alentis anuncian una alianza global para desarrollar y comercializar lixudebart para el tratamiento de enfermedades renales y hepáticas raras (opens in a new tab)

  Bolsamania · Oct 5, 2026

• CSL et Alentis annoncent un partenariat mondial visant à développer et à mettre sur le marché le lixudebart pour le traitement de maladies rares des reins et du foie (opens in a new tab)

  TradingView · Oct 5, 2026

• CSL backs Swiss Alentis’ claudin-1 bet with up to $1.6bn deal (opens in a new tab)

  European Biotechnology Magazine · Oct 5, 2026

• CSL y Alentis desarrollarán y comercializarán lixudebart para enfermedades renales y hepáticas raras (opens in a new tab)

  Bolsamania · Oct 5, 2026

• CSL joins forces with Alentis on claudin candidate (opens in a new tab)

  pharmaphorum · Oct 5, 2026